Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Soucier

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 8, 2012
Women's experiences receiving abnormal prenatal chromosomal microarray testing resultsBarbara A Bernhardt, Danielle Soucier, Karen Hanson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 14, 2012
"What does it mean?": uncertainties in understanding results of chromosomal microarray testingMarian Reiff, Barbara A Bernhardt, Surabhi Mulchandani, et al.
Journal of Patient-Reported Outcomes|March 25, 2026
Development of the Patient Satisfaction with Medication for Diabetes (PSMD) questionnaireKristina S Boye, Katie D Stewart, Louis S Matza, et al.
Breast Cancer Research and Treatment|May 14, 2017
Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancerKara N Maxwell, Danielle Soucier-Ernst, Emin Tahirovic, et al.
Breast Cancer Research and Treatment|June 28, 2017
Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancerKara N Maxwell, Danielle Soucier-Ernst, Emin Tahirovic, et al.
The Journal of Clinical Investigation|July 14, 2020
Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targetsMatt R Paul, Tien-Chi Pan, Dhruv K Pant, et al.
NPJ Breast Cancer|November 24, 2025
DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancerElizabeth M Chislock, Tien-Chi Pan, Dhruv Pant, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 8, 2012
Women's experiences receiving abnormal prenatal chromosomal microarray testing resultsBarbara A Bernhardt, Danielle Soucier, Karen Hanson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 14, 2012
"What does it mean?": uncertainties in understanding results of chromosomal microarray testingMarian Reiff, Barbara A Bernhardt, Surabhi Mulchandani, et al.
Journal of Patient-Reported Outcomes|March 25, 2026
Development of the Patient Satisfaction with Medication for Diabetes (PSMD) questionnaireKristina S Boye, Katie D Stewart, Louis S Matza, et al.
Breast Cancer Research and Treatment|May 14, 2017
Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancerKara N Maxwell, Danielle Soucier-Ernst, Emin Tahirovic, et al.
Breast Cancer Research and Treatment|June 28, 2017
Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancerKara N Maxwell, Danielle Soucier-Ernst, Emin Tahirovic, et al.
The Journal of Clinical Investigation|July 14, 2020
Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targetsMatt R Paul, Tien-Chi Pan, Dhruv K Pant, et al.
NPJ Breast Cancer|November 24, 2025
DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancerElizabeth M Chislock, Tien-Chi Pan, Dhruv Pant, et al.
Pageof 1